drugset / Trial / NCT06415045
A Study in Healthy People to Test How BI 1015550 is Taken up in the Body When Given With or Without Food
RandomizedCrossoverOpen-labelTreatment
Summary
The main objective is to investigate the effect of food on the pharmacokinetics of BI 1015550 Formulation C2.
Timeline
- Start
- 2024-05-28
- Primary completion
- 2024-07-24
- Completion
- 2024-07-24
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Nerandomilast | Small molecule | 18 mg | Oral |
Indications
No indication recorded.